These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1850876)

  • 1. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.
    España F; Estelles A; Griffin JH; Aznar J
    Thromb Haemost; 1991 Jan; 65(1):46-51. PubMed ID: 1850876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
    van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
    Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor.
    Strandberg K; Kjellberg M; Knebel R; Lilja H; Stenflo J
    Thromb Haemost; 2001 Aug; 86(2):604-10. PubMed ID: 11522010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitronectin modulates glycosaminoglycan dependent reactions of protein C inhibitor.
    Seiffert D; Geiger M; Ecke S; Binder BR
    Thromb Haemost; 1992 Dec; 68(6):657-61. PubMed ID: 1283793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein.
    Laurell M; Stenflo J
    Thromb Haemost; 1989 Nov; 62(3):885-91. PubMed ID: 2556811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma.
    España F; Estellés A; Fernández PJ; Gilabert J; Sánchez-Cuenca J; Griffin JH
    Thromb Haemost; 1993 Dec; 70(6):989-94. PubMed ID: 8165623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative ELISA for the measurement of complexes of prostate-specific antigen with protein C inhibitor when using a purified standard.
    España F; Sanchez-Cuenca J; Vera CD; Estelles A; Gilabert J
    J Lab Clin Med; 1993 Dec; 122(6):711-9. PubMed ID: 7504042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of functional and antigenic protein C inhibitor and its complexes with activated protein C in plasma by ELISA's.
    España F; Griffin JH
    Thromb Res; 1989 Sep; 55(6):671-82. PubMed ID: 2551066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
    Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
    Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma.
    Marlar RA; Kressin DC; Madden RM
    Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
    Schmaier AH; Gustafson E; Idell S; Colman RW
    J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen.
    España F; Gilabert J; Estellés A; Romeu A; Aznar J; Cabo A
    Thromb Res; 1991 Nov; 64(3):309-20. PubMed ID: 1725227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein C and its inhibitor in malignancy.
    Suzuki K; Hayashi T
    Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH; Bouma BN; Schalekamp MA
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against the heparin-dependent protein C inhibitor suitable for inhibitor purification and assay of inhibitor complexes.
    Laurell M; Carlson TH; Stenflo J
    Thromb Haemost; 1988 Oct; 60(2):334-9. PubMed ID: 3217924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro complexes of activated protein C with two inhibitors in baboons.
    España F; Gruber A; Heeb MJ; Hanson SR; Harker LA; Griffin JH
    Blood; 1991 Apr; 77(8):1754-60. PubMed ID: 1849759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.
    Tabernero D; España F; Vicente V; Estellés A; Gilabert J; Aznar J
    Thromb Haemost; 1990 Jun; 63(3):380-2. PubMed ID: 2169656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Western blot analyses of prekallikrein and its activation products in human plasma.
    Veloso D; Colman RW
    Thromb Haemost; 1991 Apr; 65(4):382-8. PubMed ID: 1711719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor.
    Meijers JC; Kanters DH; Vlooswijk RA; van Erp HE; Hessing M; Bouma BN
    Biochemistry; 1988 Jun; 27(12):4231-7. PubMed ID: 2844223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.